SCHEMBL839271

SCHEMBL839271

O=C(CCCC(=O)OCC(O)CO)OCC(O)CO

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.72
DUSP3 P51452 1/20 0.72
MEN1 O00255 1/20 0.72
KMT2A Q03164 1/20 0.72
LMNA P02545 1/20 0.72
DGKA P23743 1/20 0.60
FAAH O00519 4/20 0.57
MAPT P10636 1/20 0.46
ENPP2 Q13822 2/20 0.45
LPAR6 P43657 1/20 0.45
LPAR1 Q92633 1/20 0.45
LPAR4 Q99677 1/20 0.45
LPAR5 Q9H1C0 1/20 0.45
LPAR2 Q9HBW0 1/20 0.45
LPAR3 Q9UBY5 1/20 0.45
PRKCA P17252 3/20 0.44
PRKCE Q02156 1/20 0.44
PRKCQ Q04759 1/20 0.44
PRKCD Q05655 1/20 0.44
CNR2 P34972 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL270755 0.95 KDM4E (0.79) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL839526 0.93 LMNA (0.82) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL10797197 0.93 LMNA (0.82) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL8332902 0.93 LMNA (0.82) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL20624 0.93 LMNA (0.82) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL380177 0.93 LMNA (0.82) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL18608097 0.92 KDM4E (0.64) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL27457920 0.92 KDM4E (0.64) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL1840580 0.91 KDM4E (0.68) KDM4EDUSP3MEN1KMT2ALMNA
SCHEMBL822924 0.91 KDM4E (0.79) KDM4EDUSP3MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025111503-A1 A PRESSURE-SENSITIVE BIOADHESIVE FOR WET TISSUES AND ORGANS THE BRIGHAM AND WOMEN’S HOSPITAL, INC. (US) 2025-05-30 WO claimed
US-20230192944-A1 METHOD OF PREPARING A DEGRADABLE PRODUCT UNIV NAT TSING HUA (TW) 2023-06-22 US claimed
CN-113278273-A Degradable microparticle, degradable product containing same and application 王洁 2021-08-20 CN claimed
EP-2470220-A1 POLYMER ADHESIVE FILM FOR DIRECTED CELLULAR GROWTH Innovative Health Technologies, Llc (US) 2012-07-04 EP claimed
WO-2011025866-A1 POLYMER ADHESIVE FILM FOR DIRECTED CELLULAR GROWTH INNOVATIVE HEALTH TECHNOLOGIES, LLC (US) 2011-03-03 WO claimed
US-20110052646-A1 POLYMER ADHESIVE FILM FOR DIRECTED CELLULAR GROWTH KAIGLER SR DARNELL 2011-03-03 US claimed
US-20260096990-A1 POLYMERIC DELIVERY SYSTEMS SECANT GROUP LLC (US) 2026-04-09 US disclosed
US-12521347-B2 Polymeric delivery systems THE SECANT GROUP, LLC (US) 2026-01-13 US disclosed
US-12440446-B2 Polymeric delivery systems THE SECANT GROUP, LLC (US) 2025-10-14 US disclosed
WO-2025111503-A1 A PRESSURE-SENSITIVE BIOADHESIVE FOR WET TISSUES AND ORGANS THE BRIGHAM AND WOMEN’S HOSPITAL, INC. (US) 2025-05-30 WO disclosed
EP-4422694-A1 POLYMERIC DELIVERY SYSTEMS The Secant Group, LLC (US) 2024-09-04 EP disclosed
US-20230192944-A1 METHOD OF PREPARING A DEGRADABLE PRODUCT UNIV NAT TSING HUA (TW) 2023-06-22 US disclosed
US-20230192944-A1 METHOD OF PREPARING A DEGRADABLE PRODUCT UNIV NAT TSING HUA (TW) 2023-06-22 US disclosed
WO-2011059738-A1 IMPLANTS AND METHODS FOR PERFORMING GUMS AND BONE AUGMENTATION AND RESERVATION INNOVATIVE HEALTH TECHNOLOGIES, LLC (US) 2011-05-19 WO disclosed
US-20110117520-A1 IMPLANTS AND METHODS FOR PERFORMING GUMS AND BONE AUGMENTATION AND PRESERVATION INNOVATIVE HEALTH TECHNOLOGIES, LLC. 2011-05-19 US disclosed
WO-2011025866-A1 POLYMER ADHESIVE FILM FOR DIRECTED CELLULAR GROWTH INNOVATIVE HEALTH TECHNOLOGIES, LLC (US) 2011-03-03 WO disclosed
US-20110052646-A1 POLYMER ADHESIVE FILM FOR DIRECTED CELLULAR GROWTH KAIGLER SR DARNELL 2011-03-03 US disclosed
CN-101868253-A Formulations, methods and kits useful for the treatment of cough PROCTER & GAMBLE 2010-10-20 CN disclosed
CN-100339382-C Phospholipid derivatives and process for the production there NOF CORP (JP) 2007-09-26 CN disclosed
CN-1735624-A Phospholipid derivatives and process for the production there NOF CORP (JP) 2006-02-15 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260096990-A1 POLYMERIC DELIVERY SYSTEMS NFATC1, CHMP4B, PARG KDM4E 2531/4885DUSP3 1318/4885MEN1 2122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.